Oxana Beskrovnaya, Chief Scientific Officer at Dyne Therapeutics, Inc. (DYN), sold 4,272 shares at $31.34 ($134K) on 2024-06-11, disclosed to the SEC on 2024-06-11.
Open-market sale of $134k DYN by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $31.34 | 2,136 | $67K | 50.0% |
| 2 | $31.34 | 2,136 | $67K | 50.0% |
| Total | $31.34 avg | 4,272 | $134K | 100% |
| Filing → |
| DYN | SELL | 2025-02-25 | $36K | — | Filing → |
| DYN | SELL | 2024-12-11 | $131K | — | Filing → |
| DYN | SELL | 2024-11-18 | $161K | — | Filing → |